Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D005071:Evoked Potentials; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D009132:Muscles / Q000187:drug effects*; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D051381:Rats; D009435:Synaptic Transmission
D009388:Neostigmine; D001285:Atropine; D000324:Adrenocorticotropic Hormone; D000109:Acetylcholine; D006854:Hydrocortisone